| PACKAGING TYPE: | 1x21 C-box |
| COMPOSITION: | Palbociclib 125mg |
| FORMULATION: | Capsules |
| Description: | Palciclib 125mg Capsule is an anticancer medicine used in the treatment of hormone receptor-positive, HER2-negative breast cancer. It belongs to the group of drugs called CDK4/6 inhibitors. By slowing down or stopping the growth of cancer cells, Palciclib helps in controlling the spread of breast cancer and is usually prescribed in combination with hormonal therapies such as letrozole or fulvestrant. |
| Side Effects: | Low white blood cell count (neutropenia) Tiredness and weakness Nausea, vomiting, or diarrhea |
| Product Benefits: | Helps in the management of advanced or metastatic breast cancer. Works effectively with hormonal therapies to improve outcomes. Slows down the growth and spread of cancer cells. |




















